ISSN print edition: 0366-6352
ISSN electronic edition: 1336-9075
Registr. No.: MK SR 9/7

Published monthly
 

A Methodology for the Robust Evaluation of Pharmaceutical Processes under Uncertainty

D. B. Johnson and I. D. L. Bogle

University College London, Chemical Engineering, Torrington Place, London, WC1E 7JE, U.K.

 

E-mail: david.b.johnson@ucl.ac.uk

Received: 19 May 2000

Abstract: It is becoming widely recognized in the pharmaceutical industry that a more structured approach to process development would benefit the quality of the developed processes to ensure added value to the products in the long term. In this paper, a model-based methodology is proposed for the robust evaluation and development of pharmaceutical processes which realizes the pressures inherent to the industry and that critical decisions need to be made at all stages despite incomplete knowledge of the process. It aims to identify the most relevant process information subject to the availability and quality of the prevailing data at any given stage in the development, so that informed decisions can be made at short notice. Steps towards a multiscenario approach are proposed to resolve stochastic model parameter uncertainties in process sequences and evaluate robust performance indicators. Correlation analysis is used to provide an indication of the critical stage interactions under uncertainty so that potential causes of problems can be identified in a more rigorous manner. The potential benefits of the approach are demonstrated using a two-stage example under two parameter uncertainties. The directions required to complement a general methodology regarding practical application to real problems are indicated.

Full paper in Portable Document Format: 546aa398.pdf

 

Chemical Papers 54 (6a) 398–405 (2000)

Sunday, June 20, 2021

IMPACT FACTOR 2019
1.680
SCImago Journal Rank 2019
0.331
SEARCH
Advanced
VOLUMES
XXVIII. International Conference on Coordination and Bioinorganic Chemistry
© 2021 Chemical Papers